About Neonatal Galactose
overview
The determination is based on two reactions. In the first reaction galactose is cleaved from galactose-1-phosphate. In the second reaction galactose serves as a substrate for enzymatic reaction that produces a fluorogenic product. Fluorescence intensity of the reaction is therefore proportional to the amount of galactose in the sample.
Technical Specifications
- Neonatal Galactose, 5 solid plates (96) 480 wells 6199 851
- Neonatal Galactose, 10 solid plates (96) 960 wells 6199 850
Benefits
- Excellent reproducibility
- Good agreement with CDC samples
- Excellent analytical sensitivity
Advanced Detection for Neonatal CareOur Neonatal Galactose device utilizes state-of-the-art technology to deliver reliable galactose measurement in newborns. Given its modern design and multicolor functionality, it streamlines the diagnostic process for clinical staff and helps doctors make precise interventions. Its portability and user-friendly interface enhance its efficiency, making it particularly suitable for hospital and clinic environments requiring quick, actionable results.
Portable and User-FriendlyEngineered with convenience in mind, the Neonatal Galactose device is compact and lightweight, offering portability without compromising on performance. Medical professionals can easily transport the device between patient rooms or departments, ensuring consistent neonatal care across various hospital and clinic settings.
FAQs of Neonatal Galactose:
Q: How is the Neonatal Galactose device used in a hospital or clinical setting?
A: Medical professionals use the Neonatal Galactose device to quickly assess galactose levels in newborn blood samples. The devices modern technology streamlines the testing process, providing accurate results that aid in early diagnosis and treatment of galactosemia or similar conditions.
Q: What are the main benefits of using a multicolor, portable Neonatal Galactose device?
A: The multicolor feature enhances result interpretation, while the portable design allows for convenient movement within hospital or clinic environments. This combination ensures efficient, accurate testing and supports timely intervention for improved neonatal outcomes.
Q: When should neonatal galactose testing be performed?
A: Testing is ideally conducted soon after birth, especially in newborns who exhibit symptoms or have a family history of metabolic disorders. Early detection through this device helps initiate swift treatment and minimizes potential complications.
Q: Where can hospitals and clinics in India obtain the Neonatal Galactose device?
A: Hospitals, clinics, and healthcare distributors can acquire this device directly from leading manufacturers, suppliers, or exporters based in India. Several reputable Indian companies specialize in high-quality neonatal diagnostic equipment.
Q: What is the process for measuring galactose levels with this technology?
A: A trained clinician collects a blood sample from the newborn and applies it to the device as per the operating instructions. The device then analyzes the sample using its advanced sensors and presents results promptly, aiding in swift decision-making.
Q: How does this device improve the management of neonatal galactosemia?
A: By providing rapid and accurate galactose level readings, the device enables healthcare teams to quickly recognize and begin managing galactosemia. Early intervention is crucial for preventing complications and enhancing the long-term health of the infant.